Are you a practitioner?

Join our network
join us illustration
Oncologist
Dr Despoina Kalapanida Oncologist: Book an online appointment

Kalapanida Despoina

Oncologist Chalandri

Location

Λεωφόρος Κηφισίας 362, Chalandri, Attica

Next availability
Check availability

Why she is suitable for you

Kalapanida Despoina is a Pathologist - Oncologist and Doctor of Medicine from the Medical School of Athens, specializing in breast cancer, maintaining a private practice in Chalandri. Her goal is to provide substantive support to cancer patients at every stage of their treatment. She places particular emphasis on clear patient communication, trust, and the human doctor-patient relationship. She has significant experience as a researcher in large multicenter clinical studies, enabling her to apply modern and evidence-based therapeutic approaches. She collaborates with "Hygeia" Hospital and Euroclinic Athens and actively participates in scientific research with publications in international conferences and scientific journals.

The description was edited by the doctoranytime team, based on verified information.

Experience

Relative Experience

  • Benign diseases
  • Hepatocarcinoma
  • Breast cancer

Services

Costs are indicative and will be determined on a case by case basis

Does not provide e-prescription

Contact and location

    • Address
      Λεωφόρος Κηφισίας 362, Chalandri, Attica
    • Parking
      • No parking available
Could not find any practice in map.

Payment Methods

  • Payment Methods

    • Bank Card
    • Cash

    Appointment Policy

    • Payment at the practice

      During your visit, you can select the payment method of your choice from the options mentioned above.

    • Cancellation

      You can always cancel up to 3 hours before the appointment. For more information please read our cancellation policy.

Collaborations with Hospitals/Clinics

  • Επιμελήτρια Γ' Παθολογικής Ογκολογικής Κλινικής στο Ιδιωτικό Νοσοκομείο "Υγεία"
  • Συνεργάτιδα στην Ευρωκλινική Αθηνών

Curriculum Vitae and Career

Studies

  • PhD, National and Kapodistrian University of Athens, School of Medicine (2016 - 2019)
  • MD, National and Kapodistrian University of Athens, School of Medicine (2005 - 2012)

Professional experience

  • Attending Physician, 3rd Department of Medical Oncology, Private Hospital "Hygeia", GREECE (2022 - Present)
  • Medical Oncology Resident, University Hospital of Heraklion, Crete (2019 - 2022)
  • Medical Oncologist, Private Practice, Chalandri

Organisations member

  • HESMO (HELLENIC SOCIETY OF MEDICAL ONCOLOGY)
  • HECOG (HELLENIC COOPERATIVE ONCOLOGY GROUP)
  • ESMO (EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY)
  • ASCO (AMERICAN SOCIETY OF CLINICAL ONCOLOGY)
  • EANO (EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY)
  • EORTC (EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER)

Academic research and publications

  • Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab, 2022
  • Prognostic role of microRNAs in breast cancer: A systematic review, 2019
  • A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer, 2021
  • Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study, 2018
  • MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer, 2021
  • Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study, 2019
  • Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma, 2016
  • TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma, 2015
  • Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients, 2019
  • PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients, 2022
  • Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies, 2015
  • The Prognostic Role of Protein Expression in Pregnancy- Associated Breast Cancer: A Literature Review, 2020
  • Report from the Front: a Glimpse at Breast Cancer Research in Lowand Middle-Income Countries, 2019
  • Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients , 2023
  • ΜΕΛΕΤΗ ΜΟΝΗΡΩΝ ΠΟΛΥΜΟΡΦΙΣΜΩΝ ΣΤΟΝ ΤΡΙΠΛΑ ΑΡΝΗΤΙΚΟ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ, ΕΚΠΑ (2019)
  • Prognostic role of immune checkpoints mRNA expression in peripheral blood of non-small cell lung cancer patients treated with immune checkpoint inhibitors, 2022
  • Monitoring of PD-L1 expression on circulating immune cells of patients with small cell lung cancer (SCLC) receiving first- line treatment: Prognostic implications, 2022

Useful Links

Doctoranytime is an end-to-end solution that assists the user from the moment they experience a health symptom until the moment it is resolved, by enabling them to find the specialist they need, request guidance via chat and talk to them via video call. The information provided has been filled in by Kalapanida Despoina and edited by the doctoranytime team.
Log in or register to continue
Are you a new user? Register for free
Log in or register to continue

Continue with

or register with your email address

The password should contain at least 6 characters and 1 capital letter
Are you a registered user?
Create a new password

Enter the email you used to register in doctoranytime and we'll send you a link to create new password

Your data is in good hands
doctor-graphic doctor-graphic

doctoranytime takes your health as well as your data protection very seriously!

In order to ensure you that:

  • you will continue to get the best possible treatment from the affiliated doctors and diagnostic centers
  • you will continue to book your appointments easily and quickly by having at the same time the right of evaluation
  • we will be able to contact you immediately in case of a change in your appointment
  • you will continue to receive our newsletter and health suggestions that may interest you

it is essential for us to collect and process your personal data to the extent that you allow.

For this reason, we would like to inform you that we take all the necessary measures in order to protect your personal data, according to the New European General Data Protection Regulation (“GDPR”), the terms of the doctoranytime Privacy Policy (that you can read in detail here) and the law requirements.

If you have any questions regarding your privacy protection by doctoranytime or in case you wish to exercise your GDPR rights (information, access, correction, deletion, limitation of processing, portability of your data, objection and right to lodge a complaint with the Personal Data Protection Authority) you can contact the Data Protection Officer of doctoranytime on: [email protected].

Terms of Use

Congratulations!!

Your registration has completed.